N

Novarex Co Ltd
KOSDAQ:194700

Watchlist Manager
Novarex Co Ltd
KOSDAQ:194700
Watchlist
Price: 14 620 KRW 3.25%
Market Cap: ₩274.1B

Novarex Co Ltd
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Novarex Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
N
Novarex Co Ltd
KOSDAQ:194700
Total Equity
₩242.7B
CAGR 3-Years
11%
CAGR 5-Years
17%
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Total Equity
₩5.4T
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
5%
Amorepacific Group
KRX:002790
Total Equity
₩3.5T
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
3%
Cosmax Inc
KRX:192820
Total Equity
₩558.2B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
19%
LG H&H Co Ltd
KRX:051900
Total Equity
₩5.4T
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
10%
Kolmar Korea Co Ltd
KRX:161890
Total Equity
₩910.4B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
15%
No Stocks Found

Novarex Co Ltd
Glance View

Market Cap
274.1B KRW
Industry
Consumer products

NOVAREX Co., Ltd. engages in the manufacture and sale of dietary supplements. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2018-11-14. is a Korea-based company principally engaged in the manufacturing and distribution of health functional foods. The firm manufactures and sells nutritional supplement products containing vitamins and minerals; individual recognition products which are helpful for body fat reduction, eye health, and joint health; lactic acid bacteria containing products used for skin condition improvement. The firm also produces and sells coenzyme Q10 products, wild mango seed extract products, spirulina products, as well as others. The firm distributes its products within domestic market to overseas markets.

Intrinsic Value
17 660.79 KRW
Undervaluation 17%
Intrinsic Value
Price ₩14 620
N

See Also

What is Novarex Co Ltd's Total Equity?
Total Equity
242.7B KRW

Based on the financial report for Sep 30, 2025, Novarex Co Ltd's Total Equity amounts to 242.7B KRW.

What is Novarex Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
17%

Over the last year, the Total Equity growth was 15%. The average annual Total Equity growth rates for Novarex Co Ltd have been 11% over the past three years , 17% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett